Xopenex manufacturer?

Who is the manufacturer of Xopenex?

Xopenex, also known as levalbuterol, is a medication used for the treatment of bronchospasm associated with asthma and chronic obstructive pulmonary disease (COPD). It belongs to the class of medications known as bronchodilators.

[1] According to the website DrugPatentWatch.com, the Xopenex patent was filed by Sunovion Pharmaceuticals Inc. and the patent expires on [insert date]. Sunovion Pharmaceuticals Inc. is a pharmaceutical company based in the United States, and it is a subsidiary of Sumitomo Dainippon Pharma Co., Ltd., a Japanese multinational pharmaceutical company.

What is the history of Xopenex?

Xopenex was first approved by the U.S. Food and Drug Administration (FDA) in 2000. The drug works by relaxing the muscles in the airways, making it easier to breathe.

Where is Xopenex manufactured?

The production of Xopenex is primarily conducted at the site of Sunovion Pharmaceuticals Inc.'s partner manufacturers, as specified on the DrugPatentWatch.com website [2]. The exact manufacturing locations might not be publicly disclosed due to proprietary reasons.

What are the competitors to Xopenex?

Other medications that are classified as bronchodilators and are used to treat similar conditions as Xopenex include Albuterol, Serevent, and Foradil. However, it is essential to note that each of these medications has its unique characteristics and differences from Xopenex.

Sources:
[1] DrugPatentWatch.com - Xopenex patent information
[2] DrugPatentWatch.com - Xopenex manufacturing information